MedPath
HSA Approval

NOPERTEN 10 TABLET 10 mg

SIN12006P

NOPERTEN 10 TABLET 10 mg

NOPERTEN 10 TABLET 10 mg

July 1, 2002

APOTHECA MARKETING PTE LTD

APOTHECA MARKETING PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantAPOTHECA MARKETING PTE LTD
Licence HolderAPOTHECA MARKETING PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

C09AA03

lisinopril

Manufacturer Information

APOTHECA MARKETING PTE LTD

PT DEXA MEDICA

Active Ingredients

LISINOPRIL

10 mg

Lisinopril

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.